AbbVie Inc (BUE:ABBV)
ARS 20300 -2850 (-12.31%) Market Cap: 308.31 Tn Enterprise Value: 372.12 Tn PE Ratio: 60.57 PB Ratio: 51.09 GF Score: 68/100

Abbvie Inc at UBS Global Healthcare Conference (Virtual) Transcript

May 20, 2020 / 02:50PM GMT
Navin Cyriac Jacob
UBS Investment Bank, Research Division - Equity Research Analyst of Specialty Pharmaceuticals and Large Cap Pharmaceutic

Hello, and welcome to day 3 of the UBS Healthcare Conference. My name is Navin Jacob, senior analyst covering large-cap pharmaceuticals and smid-cap biotech. Our next presentation and fireside chat is with AbbVie. I'm very happy to have with me Mike Severino, Vice Chairman and President of AbbVie; as well as Rob Michael, CFO of AbbVie; as well as Liz Shea, Head of Investor Relations. Thank you all for joining us today.

Robert A. Michael
AbbVie Inc. - Executive VP & CFO

Thanks for having us.

Navin Cyriac Jacob
UBS Investment Bank, Research Division - Equity Research Analyst of Specialty Pharmaceuticals and Large Cap Pharmaceutic

Pleasure.

Questions & Answers

Navin Cyriac Jacob
UBS Investment Bank, Research Division - Equity Research Analyst of Specialty Pharmaceuticals and Large Cap Pharmaceutic

We are just going to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot